Polyethylene Glycol 3350
Product Images NDC 0722-6921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Polyethylene Glycol 3350 (NDC 0722-6921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexgen Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

255 G Principal Display Panel (D0d2f068 4453 4ea2 8282 339b6e497a9a 01)

255 G Principal Display Panel (D0d2f068 4453 4ea2 8282 339b6e497a9a 01)
This is a prescription laxative in a powder form for oral solution with the active ingredient of Polyethylene Glycol 3350 NF. The recommended daily dose is 17 grams per day or as directed by a physician, and the dosing cup provided is marked for convenience. The powder should be stirred in 4 to 8 oz. of water, juice, soda, coffee, or tea until completely dissolved before drinking. It may take 2 to 4 days for the product to produce a bowel movement. The medication must be kept out of the reach of children and stored in a controlled room temperature. It is manufactured by Nexgen Pharma, Inc. and distributed by Breckenridge Pharmaceutical, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.